Citačné ohlasy na publikácie našich pracovníkov registrované v roku 2009 v citačnej zahraničnej databáze SCOPUS Práca Vlcek M., Rovensky J., Blazicek P., Radikova Z., Penesova A., Kerlik J., Kvetnansky R., Imrich R. Sympathetic nervous system response to orthostatic stress in female patients with rheumatoid arthritis (2008) Annals of the New York Academy of Sciences, 1148, pp. 556-561. Citácia Is elevated noradrenaline an aetiological factor in a number of diseases? Fitzgerald, P.J. 2009 Autonomic and Autacoid Pharmacology 29 (4), pp. 143-156 Práca Lovell D.J., Ruperto N., Goodman S., Reiff A., Jung L., Jarosova K., Nemcova D., (Rovensky J...), Martini A. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis (2008) New England Journal of Medicine, 359 (8), pp. 810-820. Citácia The Paediatríc Rheumatology Expert Panel of the National Consultant for Rheumatology standpoint for the biologic therapy of juvenile idiopathic arthritis | [Stanowisko Zespotu Ekspertów ds. Reumatologii DzieciEcej przy Konsultancie Krajowym w Dziedzinie Reumatologii dotyczace terapii biologicznej w leczeniu mtodzieŃczego idiopatycznego zapalenia stawów] Rutkowska-Sak, L., Tuszkiewicz-Misztal, E., Brózik, H., Niedziela, M., Zuber, Z., Ttustochowicz, W., Wiland, P. 2009 Reumatologia 47 (3), pp. 111-115 Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: A pilot study Lionaki, S., Siamopoulos, K., Theodorou, I., Papadimitraki, E., Bertsias, G., Boumpas, D., Boletis, J. 2009 Nephrology Dialysis Transplantation 24 (7), pp. 2144-2150 Targeting innate immunity protein kinase signalling in inflammation Gaestel, M., Kotlyarov, A., Kracht, M. 2009 Nature Reviews Drug Discovery 8 (6), pp. 480-499 Biologics for treatment of juvenile idiopathic arthritis | [Biologika zur therapie der juvenilen idiopathischen arthritis] Horneff, G. 2009 Padiatrische Praxis 73 (4), pp. 701-722 Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab Katsicas, M.M., Russo, R.A.G. 2009 Clinical Rheumatology 28 (8), pp. 985-988

Efficacy of etanercept in the treatment of juvenile idiopathic arthritis | [Efectividad del etanercept en el tratamiento de la artritis idiopática juvenil] De Inocencio Arocena, J., Merino Muñoz, R., Álvarez Madrid, C., García-Consuegra Molina, J. 2009 Anales de Pediatria 70 (4), pp. 354-361 Recent developments in anti-rheumatic drugs in pediatrics: Treatment of juvenile idiopathic arthritis Hayward, K., Wallace, C.A. 2009 Arthritis Research and Therapy 11 (1), art. no. 216 Randomized controlled trial design in rheumatoid arthritis: The past decade Strand, V., Sokolove, J. 2009 Arthritis Research and Therapy 11 (1), art. no. 205 Pediatric psoriasis: Updates in biologic therapies Sukhatme, S.V., Gottlieb, A.B. 2009 Dermatologic Therapy 22 (1), pp. 34-39 Práca Smolen J.S., Beaulieu A., Rubbert-Roth A., Ramos-Remus C., Rovensky J., Alecock E., Woodworth T., Alten R. Effect of interleukin-6 receptor inhibition with to cilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial (2008) The Lancet, 371 (9617), pp. 987-997. Citácia Tocilizumab a review of its use in the management of rheumatoid arthritis Dhillon, S., Oldfield, V., Plosker, G.L. 2009 Drugs 69 (5), pp. 609-632 Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: A dreadful triad Carrero, J.J., Park, S.-H., Axelsson, J., Lindholm, B., Stenvinkel, P. 2009 Seminars in Dialysis 22 (4), pp. 381-386 Biologics for treatment of juvenile idiopathic arthritis | [Biologika zur therapie der juvenilen idiopathischen arthritis] Horneff, G. 2009 Padiatrische Praxis 73 (4), pp. 701-722 Tocilizumab and missed personalized medicine opportunities for patients with rheumatoid arthritis? Littman, B.H. 2009 Arthritis and Rheumatism 60 (5), pp. 1565-1566 Inhibition of interleukin 6, a new therapeutic option in rheumatoid arthritis | [La inhibición de la interleucina-6, una nueva opción terapéutica en la artritis reumatoide] Blanco Alonso, R., Agudo Bilbao, M. 2009 Reumatologia Clinica 5 (3), pp. 121-127 TNF-α blocking agents in rheumatoid arthritis | [TNF-α-blocker bei rheumatoider arthritis] Pieringer, H., Stuby, U., Biesenbach, G. 2009 Journal fur Mineralstoffwechsel 16 (1), pp. 7-16

Monoclonal antibodies in the treatment of systemic lupus erythematosus Robak, E., Robak, T. 2009 Current Drug Targets 10 (1), pp. 26-37 Biotherapies of autoimmune diseases: Which perspectives? | [Biothérapies des maladies auto-immunes: Quelles perspectives?] Arnaud, L., Haroche, J., Piette, J.-C., Amoura, Z. 2009 Medecine Therapeutique 15 (2), pp. 75-86 Interleukin 6 in rheumatic diseases | [Interleukin 6 u revmatických onemocnění] Mann, H. 2009 Ceska Revmatologie 17 (1), pp. 30-35 The clinical efficacy of tocilizumab in rheumatoid arthritis Mircic, M., Kavanaugh, A. 2009 Drugs of Today 45 (3), pp. 189-197 Rheumatoid arthritis - Tocilizumab: New treatment concept | [Rheumatoide arthritis - Tocilizumab: Neues behandlungskonzept] Ziegler, R. 2009 Krankenhauspharmazie 30 (2), pp. 86-88 Interleukin 6 in the physiopathology of rheumatoid arthritis | [La interleucina 6 en la fisiopatología de la artrirtis reumatoide] Álvarez, J.L.P. 2009 Reumatologia Clinica 5 (1), pp. 34-39 Latent Infection and Tuberculosis Disease in Rheumatoid Arthritis Patients Acevedo-Vásquez, E., Ponce de León, D., Gamboa-Cárdenas, R. 2009 Rheumatic Disease Clinics of North America 35 (1), pp. 163-181 Rheumatoid arthritis Klareskog, L., Catrina, A.I., Paget, S. 2009 The Lancet 373 (9664), pp. 659-672 Práca Macho L., Rovensky J., Kvetnansky R., Radikova Z., Fickova M., Zorad S. Hormone response to stress in rat strains of different susceptibility to immunologic challenge. (2008) Endocrine regulations, 42 (1), pp. 23-28. Citácia Attenuating effects of testosterone on depressive-like behavior in the forced swim test in healthy male rats Buddenberg, T.E., Komorowski, M., Ruocco, L.A., Silva, M.A.d.S., Topic, B. 2009 Brain Research Bulletin 79 (3-4), pp. 182-186 Práca Ruperto N., Ravelli A., Pistorio A., Ferriani V., Calvo I., Ganser G., Brunner J., (Rovensky J...), Martini A. The Provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core

set for the evaluation of response to therapy in juvenile dermatomyositis: A prospective validation study (2008) Arthritis Care and Research, 59 (1), pp. 4-13. Citácia Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies Dugan, E.M., Huber, A.M., Miller, F.W., Rider, L.G. 2009 Dermatology Online Journal 15 (2), art. no. 2 Práca Rovensky J., Tuchynova A. Systemic lupus erythematosus in the elderly (2008) Autoimmunity Reviews, 7 (3), pp. 235-239 Citácia The joints and rheumatoid arthritis of the elderly: Clinical, diagnostic and therapeutic-specific characteristics | [Les connectivites et la polyarthrite rhumatoïde du sujet âgé: Particularités cliniques, diagnostiques et thérapeutiques] Serraj, K., Mecili, M., Ciobanu, E., Vogel, T., Kaltenbach, G., Andrès, E. 2009 Medecine Therapeutique 15 (2), pp. 87-94 Práca Hoes J.N., Jacobs J.W.G., Boers M., Boumpas D., Buttgereit F., Caeyers N., Choy E.H., (Rovensky J...), Bijlsma J.W.J. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases (2007) Annals of the Rheumatic Diseases, 66 (12), pp. 1560-1567 Citácia Glucocorticoids in rheumatoid arthritis | [Glucocorticoides en la artritis reumatoide] López Gómez, J.M., Vela Casasempere, P. 2009 Seminarios de la Fundacion Espanola de Reumatologia 10 (2), pp. 44-47 How to choose corticosteroid in clinical use Kawai, S. 2009 Japanese Journal of Allergology 58 (1), pp. 7-12 Práca Walker U.A., Tyndall A., Czirjak L., Denton C., Farge-Bancel D., Kowal-Bielecka O., Muller-Ladner U., (Rovensky J..), Mas A.J. Clinical risk assessment of organ manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group database (2007) Annals of the Rheumatic Diseases, 66 (6), pp. 754-763.

Citácia Autoantibody testing in vasculitides and connective tissue diseases with pulmonary manifestations | [Autoantikörperdiagnostik rheumatologischer systemerkrankungen mit pulmonaler manifestation] Holle, J.U., Csernok, E., Gross, W.L. 2009 Pneumologe 6 (4), pp. 213-223 Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis Volpe, A., Ruzzenente, O., Caramaschi, P., Pieropan, S., Tinazzi, I., Carletto, A., Bambara, L.M., Biasi, D. 2009 Rheumatology International 29 (9), pp. 1073-1079 Systemic sclerosis and its pulmonary complications in The Netherlands: An epidemiological study Vonk, M.C., Broers, B., Heijdra, Y.F., Ton, E., Snijder, R., Van Dijk, A.P.J., Van Laar, J.M., (...), Van Daele, P.L.A. 2009 Annals of the Rheumatic Diseases 68 (6), pp. 961-965 Measurement of disease activity in clinical routine: Connective tissue diseases | [Krankheitsaktivitätsmessung im klinischen alltag: Kollagenosen] Leuchten, N., Aringer, M. 2009 Aktuelle Rheumatologie 34 (3), pp. 175-179 The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France Hachulla, E., De Groote, P., Gressin, V., Sibilia, J., Diot, E., Carpentier, P., Mouthon, L., (...), Giraudeau, C. 2009 Arthritis and Rheumatism 60 (6), pp. 1831-1839 Raynaud's phenomenon | [El fenómeno de Raynaud] Tolosa Vilella, C., Simeón Aznar, C.P., Gabarró Juli, L. 2009 Medicina Clinica 132 (18), pp. 712-718 A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost Caramaschi, P., Martinelli, N., Volpe, A., Pieropan, S., Tinazzi, I., Patuzzo, G., Mahamid, H., (...), Biasi, D. 2009 Clinical Rheumatology 28 (7), pp. 807-813 Nutritional evaluation and physical functional ability in scleroderma patients | [Avaliação nutricional e da capacidade funcional em doentes com esclerose sistêmica progressiva] Azevedo, V.F., de Souza Müller, C., Rinaldi, L., Bredt, M.C., Giovanni, K., Pereira, M.A.C., Volaco, F.C. 2009 Acta Reumatologica Portuguesa 34 (2), pp. 228-234 Comparison of patients with and without digital ulcers in systemic sclerosis: Detection of possible risk factors Sunderkötter, C., Herrgott, I., Brückner, C., Moinzadeh, P., Pfeiffer, C., Gerß, J., Hunzelmann, N., (...), Riemekasten, G. 2009 British Journal of Dermatology 160 (4), pp. 835-843 Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis

Low, A.H.L., Johnson, S.R., Lee, P. 2009 Journal of Rheumatology 36 (4), pp. 787-793 Systemic sclerosis: A world wide global analysis Coral-Alvarado, P., Pardo, A.L., Castaño-Rodriguez, N., Rojas-Villarraga, A., Anaya, J.-M. 2009 Clinical Rheumatology 28 (7), pp. 757-765 Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort Hanke, K., Dähnrich, C., Brückner, C.S., Huscher, D., Becker, M., Jansen, A., Meyer, W., (...), Riemekasten, G. 2009 Arthritis Research and Therapy 11 (1), art. no. R28 Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients Hanke, K., Brückner, C.S., Dähnrich, C., Huscher, D., Komorowski, L., Meyer, W., Janssen, A., (...), Riemekasten, G. 2009 Arthritis Research and Therapy 11 (1), art. no. R22 Skin sclerosis is only of limited value to identify SSc patients with severe manifestations - An analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register Hanitsch, L.G., Burmester, G.-R., Witt, C., Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., (...), Riemekasten, G. 2009 Rheumatology 48 (1), pp. 70-73 Práca Rovensky J. Asherson's syndrome - Catastrophic antiphospholipid syndrome (2006) Autoimmunity Reviews, 6 (2), pp. 61-63. Citácia What the nephrologist should know about antiphospholipid syndrome? | [Co nefrolog powinien wiedzieć o zespole antyfosfolipidowym?] Heleniak, Z., Zdrojewski, Z., Rutkowski, B. 2009 Polski Merkuriusz Lekarski 26 (153), pp. 215-219 Práca Hawkey C.J., Talley N.J., Scheiman J.M., Jones R.H., Langstrom G., Naesdal J., Yeomans N.D., (Rovensky J...), Patel A. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: The NASA2 and SPACE2 studies (2007) Arthritis Research and Therapy, 9, art. no. R17 Citácia Esomeprazole: A proton pump inhibitor Vachhani, R., Olds, G., Velanovich, V. 2009 Expert Review of Gastroenterology and Hepatology 3 (1), pp. 15-27

The pharmacology of esomeprazole and its role in gastric acid related diseases Saccar, C.L. 2009 Expert Opinion on Drug Metabolism and Toxicology 5 (9), pp. 1113-1124 Práca Rottem M., Krause I., Fraser A., Stojanovich L., Rovensky J., Shoenfeld Y. Autoimmune hemolytic anaemia in the antiphospholipid syndrome (2006) Lupus, 15 (7), pp. 473-477. Citácia Primary antiphospholipid antibody syndrome and autoimmune haemolytic anaemia - A rare combination Suhail, S., Baig, M.S., Humail, S.M., Riaz, A. 2009 Journal of the Pakistan Medical Association 59 (6), pp. 413-414 Práca Istok R., Bely M., Stancikova M., Rovensky J. Evidence for increased pyridinoline concentration in fibrotic tissues in diffuse systemic sclerosis 2001, Clinical and Experimental Dermatology, (6) 545-547 Citácia Collagen and elastin degradation products as potential activity markers of scleroderma [Degradační produkty kolagenu a elastinu jako možné ukazatele aktivity sklerodermie] Bečvář, R., Štork, J., Hulejová, H., Braun, M., Zatloukalová, I., Zatloukal, P., Jansa, P., Paleček, T. 2009 Ceska Revmatologie 17 (1), pp. 23-29 Práca Ferencik M., Novak M., Rovensky J., Rybar I. Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs. 2001, Bratislavske Lekarske Listy, (3) 123-132 Citácia L-Arginine and Alzheimer's disase Yi, J., Horky, L.L., Friedlich, A.L., Shi, Y., Rogers, J.T., Huang, X. 2009 International Journal of Clinical and Experimental Pathology 2 (3), pp. 211-238 Práca Istok R., Czirjak L., Lukac J., Stancikova M., Rovensky J. Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon 2001, Rheumatology, (2) 140-146 Citácia

Biomarkers in systemic sclerosis Doran, J.P., Veale, D.J. 2009 Rheumatology 47 (SUPPL. 5), pp. v36-v38 Collagen and elastin degradation products as potential activity markers of scleroderma [Degradační produkty kolagenu a elastinu jako možné ukazatele aktivity sklerodermie] Bečvář, R., Štork, J., Hulejová, H., Braun, M., Zatloukalová, I., Zatloukal, P., Jansa, P., Paleček, T. 2009 Ceska Revmatologie 17 (1), pp. 23-29 Práca Blazickova S., Rovensky J., Koska J., Vigas M. Effect of hyperthermic water bath on parameters of cellular immunity 2000, International Journal of Clinical Pharmacology Research, (1-2) 41-46 Citácia Therapeutic efficacy of percutaneous microwave coagulation guided with ultrasonography in rabbit renal VX2 tumor Zhang, T., Yang, B. 2009 Chinese Journal of Medical Imaging Technology 25 (3), pp. 343-346 Práca Raffayova H., Rovensky J., Malis F. Treatment with cyclosporin in patients with psoriatic arthritis: Results of clinical assessment 2000, International Journal of Clinical Pharmacology Research, (1-2) 1-11 Citácia Psoriatic arthritis: A review Eroschenko, K., Cleveland, K.W., Gunter, K. 2009 Journal of Pharmacy Practice 22 (1), pp. 86-103 Práca Pullmann Jr. R., Lukac J., Skerenova M., Rovensky J., Hybenova J., Melus V., Celec S., (...), Hyrdel R. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus 1999, Clinical and Experimental Rheumatology, (6) 725-729 Citácia CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients Ulker, M., Yazisiz, V., Sallakci, N., Avci, A.B., Sanlioglu, S., Yegin, O., Terzioglu, E. 2009 International Journal of Immunogenetics 36 (4), pp. 245-250

The soluble CTLA-4 receptor and its emerging role in autoimmune diseases Simone, R., Saverino, D. 2009 Current Immunology Reviews 5 (1), pp. 54-68 Genetic studies of systemic lupus erythematosus in Asia: Where are we now? Kim, I., Kim, Y.J., Kim, K., Kang, C., Choi, C.-B., Sung, Y.-K., Lee, H.-S., Bae, S.-C. 2009 Genes and Immunity 10 (5), pp. 421-432 Práca Zlnay D., Masaryk P., Rovensky J. Aulin (Nimesulid) - Selective inhibitor of cyclooxygenase-2 in the treatment of osteoarthritis 1998, Rheumatologia, (1) 19-24 Citácia Systematic review of non-surgical therapies for osteoarthritis of the hand: an update Mahendira, D., Towheed, T.E. 2009 Osteoarthritis and Cartilage 17 (10), pp. 1263-1268 Práca Rovensky J., Jurankova E., Rauova L., Blazickova S., Lukac J., Veselkova Z., Jezova D., Vigas M. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus 1997, Journal of Rheumatology, (12) 2330-2334 Citácia The prolactin role in systemic lupus erythematosus: Where we are Glezer, A., Paraiba, D.B., de Carvalho, J.F. 2009 Revista Brasileira de Reumatologia 49 (2), pp. 153-160 Práca Stancek D., Rovensky J. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients 1979, Acta Virologica, (2) 168-169 Citácia Systemic lupus erythematosus and Epstein-Barr virus | [Lupus et virus d'Epstein-Barr] Tazi, I., Fehri, S., Elghrari, K., Ouazzani, T., Benchemsi, N. 2009 Eastern Mediterranean Health Journal 15 (3), pp. 701-708 Práca Rovensky J., Svejcar J., Pekarek J.

Correlation between the results of the migration inhibitory factor production test with DNA and the severity of the disease in the systemic lupus erythematosus patients 1975, Zeitschrift fur Immunitatsforschung, (1) 24-30 Citácia Macrophage migration inhibitory factor: A key cytokine in RA, SLE and atherosclerosis Santos, L.L., Morand, E.F. 2009 Clinica Chimica Acta 399 (1-2), pp. 1-7 Práca Hutyrova B., Lukac J., Bosak V., Buc M., Du Bois R.M., Petrek M. Interleukin 1α Single-Nucleotide Polymorphism Associated with Systemic Sclerosis (2004) Journal of Rheumatology, 31 (1), pp. 81-84. Citácia Inflammation, Growth Factors, and Pulmonary Vascular Remodeling Hassoun, P.M., Mouthon, L., Barberà, J.A., Eddahibi, S., Flores, S.C., Grimminger, F., Jones, P.L., (...), Humbert, M. 2009 Journal of the American College of Cardiology 54 (1 SUPPL. 1), pp. S10-S19 Genetic susceptibility to systemic sclerosis. From clinical aspect to genetic factor analyses Granel, B., Bernard, F., Chevillard, C. 2009 European Journal of Internal Medicine 20 (3), pp. 242-252 Genetic basis of systemic sclerosis Yu, J., Zuo, Y.-G., Sun, Q.-N. 2009 Acta Academiae Medicinae Sinicae 31 (1), pp. 97-102 Práca Imre K., Koo E., Sesztak M., Bosak V., Bitterova O. Genetics in patients with psoriatic arthritis (2006) Orvosi Hetilap, 147 (50), pp. 2415-2419 Citácia Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway Nossent, J.C., Gran, J.T. 2009 Scandinavian Journal of Rheumatology 38 (4), pp. 251-255 Práca Zatkova A., Valero de Bernabe D.B., Polakova H., Zvarik M., Ferakova E., Bosak V., Ferak V., (...), De Cordoba S.R. High frequency of alkaptonuria in Slovakia: Evidence for the appearance of multiple mutations in HGO involving different mutational hot spots (2000) American Journal of Human Genetics, 67 (5), pp. 1333-1339

Citácia Ochronosis as an unusual cause of valvular defect: A case report Wilke, A., Steverding, D. 2009 Journal of Medical Case Reports 3, art. no. 9302 Práca Zatkova A., Polakova H., Micutkova L., Zvarik M., Bosak V., Ferakova E., Matusek J., (...), Kadasi L. Novel mutations in the homogentisate-1,2-dioxygenase gene identified in Slovak patients with alkaptonuria (2000) Journal of Medical Genetics, 37 (7), pp. 539-542. Citácia Alkaptonuria, ochronosis and ochronotic arthropathy in mainland France and the Reunion Island. A report of clinical and molecular findings in 29 patients Aquaron, R., De Córdoba, S.R., Penalva, M., Badens, C., Roux, H. 2009 Current Rheumatology Reviews 5 (2), pp. 111-125 Práca Hoffman I.E.A., Peene I., Cebecauer L., Isenberg D., Huizinga T.W.J., Union A., Meheus L., (...), De Keyser F. Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus (2005) Annals of the Rheumatic Diseases, 64 (2), pp. 330-332. Citácia What can we learn from the presence of anticyclic citrullinated peptides antibodies in systemic lupus erythematosus? | [Anticorps anti-peptides cycliques citrullinés dans le lupus érythémateux systémique] Zhao, Y., Li, J., Li, X.-x., Li, C., Li, L., Li, Z.-g. 2009 Revue du Rhumatisme (Edition Francaise) 76 (9), pp. 873-880 Práca Hoffman I.E.A., Peene I., Meheus L., Huizinga T.W.J., Cebecauer L., Isenberg D., De Bosschere K., (Cebecauer, L...), De Keyser F. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus (2004) Annals of the Rheumatic Diseases, 63 (9), pp. 1155-1158. Citácia Evaluation of C1q genomic region in minority racial groups of lupus Namjou, B., Gray-McGuire, C., Sestak, A.L., Gilkeson, G.S., Jacob, C.O., Merrill, J.T., James, J.A., (...), Harley, J.B. 2009 Genes and Immunity 10 (5), pp. 517-524

Práca Fineschi S., Borghi M.O., Riboldi P., Gariglio M., Buzio C., Landolfo S., Cebecauer L., (...), Meroni P.L. Prevalence of autoantibodies against structure specific recognition protein 1 in systemic lupus erythematosus (2004) Lupus, 13 (6), pp. 463-468. Citácia Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction Fonseca, C., Soiffer, R., Ho, V., Vanneman, M., Jinushi, M., Ritz, J., Neuberg, D., (...), Dranoff, G. 2009 Blood 113 (8), pp. 1681-1688 Práca Charles P.J., Van Venrooij W.J., Maini R.N., Smolen J.S., Penner E., Veys E., Walravens M., (Cebecauer, L..), Meretey K. The Consensus Workshops for the Detection of Autoantibodies to Intracellular Antigens in Rheumatic Diseases: 1989-1992 (1992) Clinical and Experimental Rheumatology, 10 (5), pp. 507-511 Citácia Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: A journey revisited Kumar, Y., Bhatia, A., Minz, R.W. 2009 Diagnostic Pathology 4 (1), art. no. 1 Práca Stancikova M., Lojda Z., Lukac J., Ruzickova M. Dipeptidyl peptidase IV in patients with systemic lupus erythematosus (1992) Clinical and Experimental Rheumatology, 10 (4), pp. 381-385. Citácia On the origin of serum CD26 and its altered concentration in cancer patients Cordero, O.J., Salgado, F.J., Nogueira, M. 2009 Cancer Immunology, Immunotherapy 58 (11), pp. 1725-1749 Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors Verspohl, E.J. 2009 Pharmacology and Therapeutics 124 (1), pp. 113-138 Práca Orvisky E., Soltes L., Chabrecek P., Novak I., Stancikova M. Size exclusion chromatographic characterization of sodium hyaluronate fractions prepared by high energetic sonication (1993) Chromatographia, 37 (1-2), pp. 20-22

Citácia Determination of the viscoelastic behavior of sodium hyaluronate in phosphate buffered saline with rheo-mechanical and rheo-optical methods Meyer, F., Lohmann, D., Kulicke, W.-M. 2009 Journal of Rheology 53 (4), pp. 799-818 Práca Prokopova A., Kery V., Stancikova M., Grimova J., Capek P., Sandula J., Orvisky E. Methyl-α-D-mannopyranoside, mannooligosaccharides and yeast mannans inhibit development of rat adjuvant arthritis (1993) Journal of Rheumatology, 20 (4), pp. 673-677. Citácia Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukán® in adjuvant arthritis Bauerová, K., Paulovičová, E., Mihalová, D., Švík, K., Poništ, S. 2009 Toxicology and Industrial Health 25 (4-5), pp. 329-335 Práca Orvisky E., Soltes L., Chabrecek P., Novak I., Kery V., Stancikova M., Vins I. The determination of hyaluronan molecular weight distribution by means of high-performance size exclusion chromatography (1992) Journal of Liquid Chromatography, 15 (18), pp. 3203-3218 Citácia Purification and characterization of microbial hyaluronic acid by solvent precipitation and size-exclusion chromatography Sousa, A.S., Guimarães, A.P., Goncalves, C.V., Silva, I.J., Cavalcante Jr., C.L., Azevedo, D.C.S. 2009 Separation Science and Technology 44 (4), pp. 906-923 Práca Bosmansky K., Tauchmannova H., Lukac J., Zitnan D. Assessment of Panergon therapy in progressive systemic sclerosis (1985) Zeitschrift fur Rheumatologie, 44 (5), pp. 242-245. Citácia Cold challenge to provoke a vasospastic reaction in fingers determined by temperature measurements: A systematic review Ammer, K. 2009 Thermology International 19 (4), pp. 109-118 Práca Zitnan D., Sitaj S.

Natural course of articular chondrocalcinosis. (1976) Arthritis and Rheumatism, 19 Suppl 3, pp. 363-390 Citácia Intervertebral chondrocalcinosis: An exercise in differential diagnosis in palaeopathology Mays, S.A., Dungworth, D. 2009 International Journal of Osteoarchaeology 19 (1), pp. 36-49 Práca Ebner W., Palotai T., Codreanu C., Geher P., Pahor A., Pavelka K., Smolen J., (...), Zlnay M. Ankylosing spondylitis in Central and Eastern Europe. Cross-sectional study on treatment modalities, disease activity and quality of life (2008) Zeitschrift fur Rheumatologie, 67 (6), pp. 503-510. Citácia Total hip replacement in patients with ankylosing spondylitis - Rehabilitation | [Alloplastyka stawu biodrowego u pacjentów z zesztywniajacym zapaleniem stawów krȩgosłupa - Rehabilitacja] Prusinowska, A., Turski, P., Małdyk, P., Przepiórski, E. 2009 Reumatologia 47 (4), pp. 182-187 Práca Szechinski J., Ebner W., Palotai T., Codreanu C., Geher P., Pahor A., Pavelka K., (...), Zlnay M. A cross-sectional survey of treatment patterns, disease activity, and quality of life of patients with ankylosing spondylitis in Central and Eastern Europe (2008) Reumatologia, 46 (3), pp. 130-139. Citácia Total hip replacement in patients with ankylosing spondylitis - Rehabilitation | [Alloplastyka stawu biodrowego u pacjentów z zesztywniajacym zapaleniem stawów krȩgosłupa - Rehabilitacja] Prusinowska, A., Turski, P., Małdyk, P., Przepiórski, E. 2009 Reumatologia 47 (4), pp. 182-187 Práca Kaptoge S., Armbrecht G., Felsenberg D., Lunt M., Weber K., Boonen S., Jajic I., (Masaryk P...), Reeve J. Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study (2006) Osteoporosis International, 17 (9), pp. 1369-1381.

Citácia FRAX™: A new instrument for calculating 10-year absolute fracture risk | [FRAX™: Un nuevo instrumento para calcular el riesgo absoluto de fracturas a 10 años] Claus-Hermberg, H., Bagur, A., Messina, O.D., Negri, A.L., Schurman, L., Sanchez, A. 2009 Medicina 69 (5), pp. 571-575 Práca Uitterlinden A.G., Ralston S.H., Brandi M.L., Carey A.H., Grinberg D., Langdahl B.L., Lips P., (Masaryk P...), Witteman J.C. The association between common vitamin D receptor gene variations and osteoporosis: A participant-level meta-analysis (2006) Annals of Internal Medicine, 145 (4), pp. 255-264. Citácia Genes and osteoporosis: Time for a change in strategy Giroux, S., Rousseau, F. 2009 International Journal of Clinical Rheumatology 4 (2), pp. 221-233 Evaluation and management of osteoporosis and fragility fractures in the elderly Rosenzweig, A., Mishra, R. 2009 Aging Health 5 (6), pp. 833-850 Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data Randerson-Moor, J.A., Taylor, J.C., Elliott, F., Chang, Y.-M., Beswick, S., Kukalizch, K., Affleck, P., (...), Bishop, J.A.N. 2009 European Journal of Cancer 45 (18), pp. 3271-3281 Collaborative meta-analysis: Associations of 150 candidate genes with osteoporosis and osteoporotic fracture Richards, J.B., Kavvoura, F.K., Rivadeneira, F., Styrkársdóttir, U., Estrada, K., Halldórsson, B.V., Hsu, Y.-H., (...), Spector, T.D. 2009 Annals of Internal Medicine 151 (8), pp. 528-537 Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns Laaksonen, M.M.L., Outila, T.A., Kärkkäinen, M.U.M., Kemi, V.E., Rita, H.J., Perola, M., Valsta, L.M., Lamberg-Allardt, C.J.E. 2009 Journal of Nutrigenetics and Nutrigenomics 2 (2), pp. 55-63 Higher milk requirements for bone mineral accrual in adolescent girls bearing specific Caucasian genotypes in the VDR promoter Esterle, L., Jehan, F., Sabatier, J.-P., Garabedian, M. 2009 Journal of Bone and Mineral Research 24 (8), pp. 1389-1397 Association of genetic polymorphisms in several vitamin D receptor gene sites with bone mineral density and biochemical markers of bone turnover in postmenopausal women Ge, J.-R., Xie, L.-H., Chen, K., Zeng, X.-A., Lai, Y.-L., Li, S.-Q., Xue, L. 2009 Journal of Clinical Rehabilitative Tissue Engineering Research 13 (28), pp. 5593-5596

The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density Mencej-Bedrač, S., Preželi, J., Kocjan, T., Teskač, K., Ostanek, B., Šmelcer, M., Marc, J. 2009 Journal of Molecular Endocrinology 42 (3), pp. 239-247 Update on the pharmacogenetics of the vitamin D receptor and osteoporosis Gennari, L., Merlotti, D., De Paola, V., Martini, G., Nuti, R. 2009 Pharmacogenomics 10 (3), pp. 417-433 Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: A meta-analysis Xu, C., Zhou, H., Gu, M. 2009 Clinical Endocrinology 70 (6), pp. 938-945 Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse Xiong, Q., Jiao, Y., Hasty, K.A., Canale, S.T., Stuart, J.M., Beamer, W.G., Deng, H.-W., (...), Gu, W. 2009 Genomics 93 (5), pp. 401-414 The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes Brodowska, A., Starczewski, A., Brodowski, J., Szydowska, I., Nawrocka-Rutkowska, J. 2009 Gynecological Endocrinology 25 (5), pp. 315-323 Common variants in the region around Osterix are associated with bone mineral density and growth in childhood Timpson, N.J., Tobias, J.H., Richards, J.B., Soranzo, N., Duncan, E.L., Sims, A.-M., Whittaker, P., (...), Evans, D.M. 2009 Human Molecular Genetics 18 (8), pp. 1510-1517 Genome-wide Association and Follow-Up Replication Studies Identified ADAMTS18 and TGFBR3 as Bone Mass Candidate Genes in Different Ethnic Groups Xiong, D.-H., Liu, X.-G., Guo, Y.-F., Tan, L.-J., Wang, L., Sha, B.-Y., Tang, Z.-H., (...), Deng, H.-W. 2009 American Journal of Human Genetics 84 (3), pp. 388-398 Haplotypes of promoter and intron 1 polymorphisms in the COLIA1 gene are associated with increased risk of osteoporosis Husted, L.B., Harsløf, T., Gonzalez-Bofill, N., Schmitz, A., Carstens, M., Stenkjær, L., Langdahl, B.L. 2009 Calcified Tissue International 84 (2), pp. 85-96 Práca O'Neill T.W., Cockerill W., Matthis C., Raspe H.H., Lunt M., Cooper C., Banzer D., (Masaryk P...), Silman A.J. Back pain, disability, and radiographic vertebral fracture in European women: A prospective study (2004) Osteoporosis International, 15 (9), pp. 760-765. Citácia Kyphosis and vertebral fractures: What do we know now?

Lewiecki, E.M. 2009 Aging Health 5 (4), pp. 483-487 Painful osteoporotic vertebral fractures (kyphotic postural changes, acute and chronic back pain, outcomes and limits of vertebroplasty and kyphoplasty) | [Ostéoporose vertébrale douloureuse (troubles statiques, douleurs séquellaires, limites de la cimentoplastie et de la cyphoplastie)] Javier, R.-M., Gangi, A. 2009 Revue du Rhumatisme (Edition Francaise) 76 (6), pp. 566-572 Vertebral compression fractures among older adults Abid, S., Papaioannou, A. 2009 Geriatrics and Aging 12 (1), pp. 10-20 Práca Cockerill W., Lunt M., Silman A.J., Cooper C., Lips P., Bhalla A.K., Cannata J.B., (.Masaryk P..), O'Neill T.W. Health-related quality of life and radiographic vertebral fracture (2004) Osteoporosis International, 15 (2), pp. 113-119. Citácia Osteoporosis: Background and Overview Knudtson, M. 2009 Journal for Nurse Practitioners 5 (6 SUPPL. 1), pp. S4-S12 Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women - Update 2009 | [Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose - Update 2009] Dimai, H.P., Pietschmann, P., Resch, H., Preisinger, E., Fahrleitner-Pammer, A., Dobnig, H., Klaushofer, K. 2009 Wiener Medizinische Wochenschrift 159 (SUPPL. 122), pp. 1-34 Práca Lunt M., O'Neill T.W., Felsenberg D., Reeve J., Kanis J.A., Cooper C., Silman A.J., (Masaryk P...), Woolf A.D. Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: Results from the European Prospective Osteoporosis Study (EPOS) (2003) Bone, 33 (4), pp. 505-513. Citácia Which women should be selected for vertebral fracture assessment? Comparing different methods of targeting VFA Middleton, E.T., Gardiner, E.D., Steel, S.A. 2009 Calcified Tissue International 85 (3), pp. 203-210 FRAX® and its applications to clinical practice Kanis, J.A., Oden, A., Johansson, H., Borgström, F., Ström, O., McCloskey, E. 2009 Bone 44 (5), pp. 734-743

Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women - Update 2009 | [Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose - Update 2009] Dimai, H.P., Pietschmann, P., Resch, H., Preisinger, E., Fahrleitner-Pammer, A., Dobnig, H., Klaushofer, K. 2009 Wiener Medizinische Wochenschrift 159 (SUPPL. 122), pp. 1-34 The International Commission on Radiation Units and Measurements DeLuca Jr., P.M. 2009 Journal of the ICRU 9 (1), pp. 3-115 Preliminary biomechanical evaluation of prophylactic vertebral reinforcement adjacent to vertebroplasty under cyclic loading Oakland, R.J., Furtado, N.R., Wilcox, R.K., Timothy, J., Hall, R.M. 2009 Spine Journal 9 (2), pp. 174-181 Prophylactic Vertebroplasty. Cement Injection into Non-fractured Vertebral Bodies During Percutaneous Vertebroplasty Kobayashi, N., Numaguchi, Y., Fuwa, S., Uemura, A., Matsusako, M., Okajima, Y., Ishiyama, M., Takahashi, O. 2009 Academic Radiology 16 (2), pp. 136-143 The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: Its relation to fracture level, type of fracture and grade of fracture deformation Suzuki, N., Ogikubo, O., Hansson, T. 2009 European Spine Journal 18 (1), pp. 77-88 Práca Roy D.K., O'Neill T.W., Finn J.D., Lunt M., Silman A.J., Felsenberg D., Armbrecht G., (Masaryk P...), Reeve J. Determinants of incident vertebral fracture in men and women: Results from the European Prospective Osteoporosis Study (EPOS) (2003) Osteoporosis International, 14 (1), pp. 19-26 Citácia Variation in risk factors for fractures at different sites Kelsey, J.L., Samelson, E.J. 2009 Current Osteoporosis Reports 7 (4), pp. 127-133 Práca Roy D.K., Pye S.R., Lunt M., O'Neill T.W., Todd C., Raspe H., Reeve J., (Masaryk P...), Woolf A.D. Falls explain between-center differences in the incidence of limb fracture across Europe (2002) Bone, 31 (6), pp. 712-717. Citácia From relative risk to absolute fracture risk calculation: The FRAX algorithm McCloskey, E.V., Johansson, H., Oden, A., Kanis, J.A. 2009 Current Osteoporosis Reports 7 (3), pp. 77-83

Variation in fracture rates by country may not be explained by differences in bone mass Eklund, F., Nordström, A., Neovius, M., Svensson, O., Nordström, P. 2009 Calcified Tissue International 85 (1), pp. 10-16 Práca O'Neill T.W., Lunt M., Silman A.J., Felsenberg D., Benevolenskaya L.I., Bhalla A.K., Cannata J.B., (Masaryk P...), Reeve J. The relationship between bone density and incident vertebral fracture in men and women (2002) Journal of Bone and Mineral Research, 17 (12), pp. 2214-2221. Citácia Male osteoporosis: Diagnosis and fracture risk evaluation | [Ostéoporose masculine : démarche diagnostique. Identification des hommes à risque de fracture et identification des patients nécessitant un traitement] Briot, K., Cortet, B., Trémollières, F., Sutter, B., Thomas, T., Roux, C., Audran, M. 2009 Revue du Rhumatisme (Edition Francaise) 76 (3), pp. 216-221 Práca Lunt M., Ismail A.A., Felsenberg D., Cooper C., Kanis J.A., Reeve J., Silman A.J., (Masaryk P...), Woolf A.D. Defining incident vertebral deformities in population studies: A comparison of morphometric criteria (2002) Osteoporosis International, 13 (10), pp. 809-815. Citácia A simple radiological method for recognizing osteoporotic thoracic vertebral compression fractures and distinguishing them from scheuermann disease Masharawi, Y., Rothschild, B., Peled, N., Hershkovitz, I. 2009 Spine 34 (18), pp. 1995-1999 Práca Ismail A.A., Pye S.R., Cockerill W.C., Lunt M., Silman A.J., Reeve J., Banzer D., (Masaryk P...), O'Neill T.W. Incidence of limb fracture across Europe: Results from the European prospective osteoporosis study (EPOS) (2002) Osteoporosis International, 13 (7), pp. 565-571. Citácia Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's bone disease Doggrell, S.A. 2009 Expert Review of Endocrinology and Metabolism 4 (5), pp. 405-415

Práca Felsenberg D., Silman A.J., Lunt M., Armbrecht G., Ismail A.A., Finn J.D., Cockerill W.C., (Masaryk P...), O'Neill T.W. Incidence of vertebral fracture in europe: Results from the european prospective osteoporosis study (EPOS) (2002) Journal of Bone and Mineral Research, 17 (4), pp. 716-724. Citácia New perspectives on the definition and the management of severe osteoporosis: The patient with two or more fragility fractures Nuti, R., Brandi, M.L., Isaia, G., Tarantino, U., Silvestris, S., Adami, S. 2009 Journal of Endocrinological Investigation 32 (9), pp. 783-788 Safety and efficacy of vertebroplasty: Early results of a prospective one-year case series of osteoporosis patients in an academic high-volume center Diel, P., Merky, D., Röder, C., Popp, A., Perler, M., Heini, P.F. 2009 Indian Journal of Orthopaedics 43 (3), pp. 228-233 Osteoporosis: Whom, when and how to treat? | [Osteoporóza: Koho, kdy a jak léčit?] Štěpán, J. 2009 Casopis Lekaru Ceskych 148 (1), pp. 25-33 1150 Kyphoplasties over 7 years: Indications, techniques, and intraoperative complications McArthur, N., Kasperk, C., Baier, M., Tanner, M., Gritzbach, B., Schoierer, O., Rothfischer, W., (...), Huber, F.-X. 2009 Orthopedics 32 (2), pp. 90 Vertebral compression fractures among older adults Abid, S., Papaioannou, A. 2009 Geriatrics and Aging 12 (1), pp. 10-20 Práca Ismail A.A., Cockerill W., Cooper C., Finn J.D., Abendroth K., Parisi G., Banzer D., (Masaryk P...), O'Neill T.W. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: Results from the European prospective osteoporosis study (2001) Osteoporosis International, 12 (2), pp. 85-90. Citácia Clinical relevance of diagnosing vertebral fractures by vertebral fracture assessment Van Brussel, M.S., Lems, W.F. 2009 Current Osteoporosis Reports 7 (3), pp. 103-106 Male osteoporosis: Diagnosis and fracture risk evaluation | [Ostéoporose masculine : démarche diagnostique. Identification des hommes à risque de fracture et identification des patients nécessitant un traitement] Briot, K., Cortet, B., Trémollières, F., Sutter, B., Thomas, T., Roux, C., Audran, M. 2009 Revue du Rhumatisme (Edition Francaise) 76 (3), pp. 216-221

Práca Cockerill W., Ismail A.A., Cooper C., Matthis C., Raspe H., Silman A.J., O'Neill T.W., (Masaryk P...), Woolf A.D. Does location of vertebral deformity within the spine influence back pain and disability? (2000) Annals of the Rheumatic Diseases, 59 (5), pp. 368-371. Citácia Bone creep can cause progressive vertebral deformity Pollintine, P., Luo, J., Offa-Jones, B., Dolan, P., Adams, M.A. 2009 Bone 45 (3), pp. 466-472 Thoracic spine pain in the general population: Prevalence, incidence and associated factors in children, adolescents and adults. A systematic review Briggs, A.M., Smith, A.J., Straker, L.M., Bragge, P. 2009 BMC Musculoskeletal Disorders 10 (1), art. no. 77 The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: Its relation to fracture level, type of fracture and grade of fracture deformation Suzuki, N., Ogikubo, O., Hansson, T. 2009 European Spine Journal 18 (1), pp. 77-88 Práca Ismail A.A., O'Neill T.W., Cockerill W., Finn J.D., Cannata J.B., Hoszowski K., Johnell O., (.Masaryk P..), Woolf A.D. Validity of self-report of fractures: Results from a prospective study in men and women across Europe (2000) Osteoporosis International, 11 (3), pp. 248-254. Citácia Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data Cheng, H., Gary, L.C., Curtis, J.R., Saag, K.G., Kilgore, M.L., Morrisey, M.A., Matthews, R., (...), Delzell, E. 2009 Osteoporosis International 20 (9), pp. 1507-1515 The Global Longitudinal Study of Osteoporosis in Women (GLOW): Rationale and study design Hooven, F.H., Adachi, J.D., Adami, S., Boonen, S., Compston, J., Cooper, C., Delmas, P., (...), Anderson Jr., F.A. 2009 Osteoporosis International 20 (7), pp. 1107-1116 Clinical subsequent fractures cluster in time after first fractures Van Geel, T.A.C.M., Van Helden, S., Geusens, P.P., Winkens, B., Dinant, G.-J. 2009 Annals of the Rheumatic Diseases 68 (1), pp. 99-102 A1330V polymorphism of low-density lipoprotein receptor-related protein 5 gene and self-reported incident fractures in Japanese female patients with rheumatoid arthritis

Furuya, T., Urano, T., Ikari, K., Kotake, S., Inoue, S., Hara, M., Momohara, S., (...), Yamanaka, H. 2009 Modern Rheumatology 19 (2), pp. 140-146 Práca Ismail A.A., Cooper C., Felsenberg D., Varlow J., Kanis J.A., Silman A.J., O'Neill T.W., (Masaryk P...), Woolf A.D. Number and type of vertebral deformities: Epidemiological characteristics and relation to back pain and height loss (1999) Osteoporosis International, 9 (3), pp. 206-213 Citácia Kyphosis and vertebral fractures: What do we know now? Lewiecki, E.M. 2009 Aging Health 5 (4), pp. 483-487 Bone creep can cause progressive vertebral deformity Pollintine, P., Luo, J., Offa-Jones, B., Dolan, P., Adams, M.A. 2009 Bone 45 (3), pp. 466-472 Which women should be selected for vertebral fracture assessment? Comparing different methods of targeting VFA Middleton, E.T., Gardiner, E.D., Steel, S.A. 2009 Calcified Tissue International 85 (3), pp. 203-210 Relationship between historical height loss and vertebral fractures in postmenopausal women Bennani, L., Allali, F., Rostom, S., Hmamouchi, I., Khazzani, H., Mansouri, L., Ichchou, L., (...), Hajjaj-Hassouni, N. 2009 Clinical Rheumatology 28 (11), pp. 1283-1289 Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: Results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program Halton, J., Gaboury, I., Grant, R., Alos, N., Cummings, E.A., Matzinger, M., Shenouda, N., (...), Reed, M. 2009 Journal of Bone and Mineral Research 24 (7), pp. 1326-1334 Kinematics of the lumbar spine in elderly subjects with decreased bone mineral density Ma, H.T., Griffith, J.F., Yang, Z., Kwok, A.W.L., Leung, P.C., Lee, R.Y.W. 2009 Medical and Biological Engineering and Computing 47 (7), pp. 783-789 Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men Pasco, J.A., Henry, M.J., Korn, S., Nicholson, G.C., Kotowicz, M.A. 2009 Osteoporosis International 20 (5), pp. 787-792 Identification of vertebral deformities in the Polish population by morphometric X-ray absorptiometry - Results of the EPOLOS study

Skowrońska-Jóźwiak, E., Płudowski, P., Karczmarewicz, E., Lorenc, R., Lewiński, A., Adamczewski, Z., Bielecka, L., (...), Zygmunt, A. 2009 Endokrynologia Polska 60 (2), pp. 68-75 Evaluation of osteoporotic fractures in a group of Turkish women Odabaşi, E., Turan, M., Tekbaş, F., Kutlu, M. 2009 Turkish Journal of Medical Sciences 39 (1), pp. 21-28 The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: Its relation to fracture level, type of fracture and grade of fracture deformation Suzuki, N., Ogikubo, O., Hansson, T. 2009 European Spine Journal 18 (1), pp. 77-88 Práca Lunt M., Felsenberg D., Reeve J., Benevolenskaya L., Cannata J., Dequeker J., Dodenhof C., (Masaryk P...), Silman A.J. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: The EVOS study (1997) Journal of Bone and Mineral Research, 12 (11), pp. 1883-1894. Citácia The International Commission on Radiation Units and Measurements DeLuca Jr., P.M. 2009 Journal of the ICRU 9 (1), pp. 3-115 Práca Lunt M., Felsenberg D., Adams J., Benevolenskaya L., Cannata J., Dequeker J., Dodenhof C., (Masaryk P...), Reeve J. Population-based geographic variations in DXA bone density in Europe: The EVOS study (1997) Osteoporosis International, 7 (3), pp. 175-189 Citácia Comparison of bone mineral density in Isfahani women with other populations: The impact on diagnosis of using different normal ranges Salamat, M.R., Tavakoli, M.B., Salehi, M., Pishva, E., Salari, A.H., Tabesh, F. 2009 Asian Journal of Scientific Research 2 (1), pp. 61-67 Práca Silman A.J., O'Neill T.W., Cooper C., Kanis J., Felsenberg D., Abendroth K., Agnusdei D., (.Masaryk P..), Ziegler R. Influence of physical activity on vertebral deformity in men and women: Results from the European Vertebral Osteoporosis Study (1997) Journal of Bone and Mineral Research, 12 (5), pp. 813-819

Citácia The link between physical activity and bone strength across the lifespan MacDonald,H.M., Ashe, M.C., McKay, H.A. 2009 International Journal of Clinical Rheumatology 4 (4), pp. 437-463 Práca O'Neill T.W., Silman A.J., Naves Diaz M., Cooper C., Kanis J., Felsenberg D., Agnusdei D., (.Masaryk P..), Woolf A.D. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women (1997) Osteoporosis International, 7 (1), pp. 72-78. Citácia The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health Guilbert, E.R., Brown, J.P., Kaunitz, A.M., Wagner, M.-S., Bérubé, J., Charbonneau, L., Francoeur, D., (...), Morin, R. 2009 Contraception 79 (3), pp. 167-177 Práca Matthis C., Weber U., O'Neill T.W., Raspe H., Agnusdei D., Bergmann K., Cooper C., (Masaryk P...), Woolf A.D. Health impact associated with vertebral deformities: Results from the european vertebral osteoporosis study (EVOS) (1998) Osteoporosis International, 8 (4), pp. 364-372. Citácia TAC ósea en la vertebroplastia percutánea Solá Suárez, M., Pérez Andrés, R., Puyalto de Pablo, P., Cuadras Collsamata, P., Calvo Bota, E., Vallejos Arroyo, V., López-Amor, M.F. 2009 Revista Espanola de Medicina Nuclear 28 (6), pp. 291-294 Amplified back pain and comorbidity in the population | [Amplifizierte Rückenschmerzen und Komorbidität in der Bevölkerung] Hüppe, A., Raspe, H. 2009 Schmerz 23 (3), pp. 275-283 Vertebroplasty and kyphoplasty: Complementary techniques for the treatment of painful osteoporotic vertebral compression fractures. A prospective non-randomised study on 154 patients Lovi, A., Teli, M., Ortolina, A., Costa, F., Fornari, M., Brayda-Bruno, M. 2009 European Spine Journal 18 (SUPPL. 1), pp. S95-S101 Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men Pasco, J.A., Henry, M.J., Korn, S., Nicholson, G.C., Kotowicz, M.A. 2009 Osteoporosis International 20 (5), pp. 787-792

The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: Its relation to fracture level, type of fracture and grade of fracture deformation Suzuki, N., Ogikubo, O., Hansson, T. 2009 European Spine Journal 18 (1), pp. 77-88 Vertebroplasty and kyphoplasty: Complementar tecniques for the treatment of painful osteoporotic vertebral compression fractures Lovi, A., Teli, M., Ortolina, A., Costa, F., Fornari, M., Brayda-Bruno, M. 2009 Coluna/ Columna 8 (1), pp. 57-62